In a milestone for medical aesthetics, Dr Uzair Khan drives Estheticare & Getz Pharma’s Tirzepatide debut in Islamabad
In a significant step forward for Pakistan's Aesthetic and Healthcare sector, Estheticare Clinic and pharmaceutical giant Getz Pharma have joined forces in a strategic alliance to raise awareness about Tirzepatide, a revolutionary treatment for obesity and type 2 diabetes. Drug administration of Trizpetide has been recently approved by the Drug Regulatory Authority of Pakistan.
This collaborative initiative, spearheaded by Dr. Uzair Khan, founder and CEO of Estheticare Clinic, marks an important milestone in bringing world-class metabolic health solutions to Islamabad, Pakistan.
A strategic healthcare alliance
This partnership represents a joint venture between two industry leaders—Getz Pharma's pharmaceutical excellence and Estheticare's clinical innovation—working together to educate healthcare professionals and the public about this groundbreaking treatment option.
Continue Reading on The Express Tribune
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.